164 related articles for article (PubMed ID: 17047653)
21. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
[TBL] [Abstract][Full Text] [Related]
22. TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management.
Hassan HM; Dave BJ; Singh RK
Curr Mol Med; 2014 May; 14(4):432-9. PubMed ID: 24730526
[TBL] [Abstract][Full Text] [Related]
23. Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.
Di Vinci A; Sessa F; Casciano I; Banelli B; Franzi F; Brigati C; Allemanni G; Russo P; Dominioni L; Romani M
Int J Oncol; 2009 Feb; 34(2):449-56. PubMed ID: 19148480
[TBL] [Abstract][Full Text] [Related]
24. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.
Palani M; Devan S; Arunkumar R; Vanisree AJ
Med Oncol; 2011 Dec; 28 Suppl 1():S445-52. PubMed ID: 20844987
[TBL] [Abstract][Full Text] [Related]
25. Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.
Chen Y; Wang Y; He Q; Wang W; Zhang T; Wang Z; Dong J; Lan Q; Zhao J
Cancer Med; 2021 Jul; 10(13):4644-4657. PubMed ID: 34121368
[TBL] [Abstract][Full Text] [Related]
26. The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.
Holcakova J; Ceskova P; Hrstka R; Muller P; Dubska L; Coates PJ; Palecek E; Vojtesek B
Cell Mol Biol Lett; 2008; 13(3):404-20. PubMed ID: 18350258
[TBL] [Abstract][Full Text] [Related]
27. Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer.
Logotheti S; Michalopoulos I; Sideridou M; Daskalos A; Kossida S; Spandidos DA; Field JK; Vojtesek B; Liloglou T; Gorgoulis V; Zoumpourlis V
FEBS J; 2010 Jul; 277(14):3014-27. PubMed ID: 20528922
[TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour.
Song D; Yue L; Wu G; Ma S; Yang H; Liu Q; Zhang D; Xia Z; Jia J; Wang J
J Clin Pathol; 2016 Jan; 69(1):12-8. PubMed ID: 26184366
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of p73Deltaex2 transcript in uveal melanoma with loss of chromosome 1p.
Kilic E; Brüggenwirth HT; Meier M; Naus NC; Beverloo HB; Meijerink JP; Luyten GP; de Klein A
Melanoma Res; 2008 Jun; 18(3):208-13. PubMed ID: 18477895
[TBL] [Abstract][Full Text] [Related]
31. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
32. Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.
Marabese M; Marchini S; Marrazzo E; Mariani P; Cattaneo D; Fossati R; Compagnoni A; Signorelli M; Moll UM; Codegoni AM; Broggini M
Eur J Cancer; 2008 Jan; 44(1):131-41. PubMed ID: 18039564
[TBL] [Abstract][Full Text] [Related]
33. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
34. p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival.
Zitterbart K; Zavrelova I; Kadlecova J; Spesna R; Kratochvilova A; Pavelka Z; Sterba J
Acta Neuropathol; 2007 Dec; 114(6):641-50. PubMed ID: 17912537
[TBL] [Abstract][Full Text] [Related]
35. TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease.
Li Q; Athan ES; Wei M; Yuan E; Rice SL; Vonsattel JP; Mayeux RP; Tycko B
BMC Med Genet; 2004 Jun; 5():14. PubMed ID: 15175114
[TBL] [Abstract][Full Text] [Related]
36. High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.
Lucena-Araujo AR; Kim HT; Thomé C; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Glória AB; Chauffaille Mde L; Athayde M; Chiattone CS; Mito I; Bendlin R; Souza C; Bortolheiro C; Coelho-Silva JL; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Blood; 2015 Nov; 126(20):2302-6. PubMed ID: 26429976
[TBL] [Abstract][Full Text] [Related]
37. Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors.
Vilgelm AE; Hong SM; Washington MK; Wei J; Chen H; El-Rifai W; Zaika A
Oncogene; 2010 Oct; 29(43):5861-8. PubMed ID: 20676143
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
[TBL] [Abstract][Full Text] [Related]
39. Relative expression of TAp73 and ΔNp73 isoforms.
Conforti F; Yang AL; Agostini M; Rufini A; Tucci P; Nicklison-Chirou MV; Grespi F; Velletri T; Knight RA; Melino G; Sayan BS
Aging (Albany NY); 2012 Mar; 4(3):202-5. PubMed ID: 22388545
[TBL] [Abstract][Full Text] [Related]
40. Prognostic and predictive impact of MGMT promoter methylation in grade 3 gliomas.
Haque W; Thong E; Andrabi S; Verma V; Brian Butler E; Teh BS
J Clin Neurosci; 2021 Mar; 85():115-121. PubMed ID: 33581781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
